| __timestamp | Amneal Pharmaceuticals, Inc. | Amphastar Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 449634000 | 51256000 |
| Thursday, January 1, 2015 | 499226000 | 77347000 |
| Friday, January 1, 2016 | 597455000 | 104189000 |
| Sunday, January 1, 2017 | 526178000 | 90795000 |
| Monday, January 1, 2018 | 716403000 | 106985000 |
| Tuesday, January 1, 2019 | 352997000 | 131923000 |
| Wednesday, January 1, 2020 | 628393000 | 143340000 |
| Friday, January 1, 2021 | 768973000 | 199739000 |
| Saturday, January 1, 2022 | 784708000 | 248860000 |
| Sunday, January 1, 2023 | 820565000 | 351121000 |
Unveiling the hidden dimensions of data
In the competitive landscape of pharmaceuticals, Amneal Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc. have showcased intriguing trajectories in their gross profit margins over the past decade. From 2014 to 2023, Amneal's gross profit surged by approximately 82%, peaking in 2023. This growth reflects their strategic expansions and product innovations. Meanwhile, Amphastar demonstrated a remarkable 585% increase in the same period, highlighting their robust market penetration and operational efficiencies.
Amneal's gross profit consistently outpaced Amphastar's, with a notable spike in 2018, reaching nearly 716 million. However, Amphastar's growth trajectory was steeper, culminating in a significant leap in 2023, where their gross profit reached 351 million. This analysis underscores the dynamic nature of the pharmaceutical industry, where strategic decisions and market adaptability play pivotal roles in financial performance.
Gross Profit Analysis: Comparing Eli Lilly and Company and Amneal Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Incyte Corporation and Amneal Pharmaceuticals, Inc.
Walgreens Boots Alliance, Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Exelixis, Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Grifols, S.A. vs Amphastar Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Corcept Therapeutics Incorporated or Amneal Pharmaceuticals, Inc.
Gross Profit Comparison: Amneal Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. Trends
Gross Profit Comparison: Amneal Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd. Trends
Research and Development Investment: Amneal Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Key Insights on Gross Profit: Amneal Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Amneal Pharmaceuticals, Inc. and MiMedx Group, Inc.
Gross Profit Trends Compared: Vericel Corporation vs Amphastar Pharmaceuticals, Inc.